Vicapsys Life Sciences, Inc. (VICP)
1.00
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Vicapsys Life Sciences SG&A Expense (TTM) : -0.0004M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0004M |
| March 31, 2025 | -0.0007M |
| December 31, 2024 | -0.0023M |
| September 30, 2024 | 0.0365M |
| June 30, 2024 | 0.0593M |
| March 31, 2024 | 0.0746M |
| December 31, 2023 | 0.0784M |
| September 30, 2023 | 0.065M |
| June 30, 2023 | 0.0503M |
| March 31, 2023 | 0.0512M |
| December 31, 2022 | 0.0602M |
| September 30, 2022 | 0.0506M |
| June 30, 2022 | 0.047M |
| March 31, 2022 | 0.04M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0358M |
| September 30, 2021 | 0.0369M |
| June 30, 2021 | 0.0418M |
| March 31, 2021 | 0.0414M |
| December 31, 2020 | 0.047M |
| September 30, 2020 | 0.0553M |
| June 30, 2020 | 0.0503M |
| March 31, 2020 | 0.2063M |
| December 31, 2019 | 0.5143M |
| June 30, 2019 | 0.7378M |
| December 31, 2018 | 0.7293M |
| March 31, 2010 | 0.5643M |
| March 31, 2009 | 0.2423M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |
| Sangamo Therapeutics, Inc. | 31.64M |
| Sarepta Therapeutics, Inc. | 436.74M |
| Anixa Biosciences, Inc. | 6.118M |